Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/SANOFI-4698/news/Sanofi-Late-breaking-ESMO-presentation-shows-Libtayo-cemiplimab-monotherapy-increases-overall-31331041/?utm_source=whatsapp&utm_medium=social&utm_campaign=share